1	Levels	Level	B-NP	NNS	O	8	SUB	-1
2	of	of	B-PP	IN	O	1	NMOD	-1
3	expression	expression	B-NP	NN	O	2	PMOD	9	expression
4	of	of	B-PP	IN	O	3	NMOD	-1
5	CYR61	CYR61	B-NP	NN	B-protein	7	NMOD	-1
6	and	and	I-NP	CC	O	7	NMOD	-1
7	CTGF	CTGF	I-NP	NN	B-protein	4	PMOD	-1
8	are	be	B-VP	VBP	O	0	ROOT	-1
9	prognostic	prognostic	B-ADJP	JJ	O	8	PRD	-1
10	for	for	B-PP	IN	O	9	AMOD	-1
11	tumor	tumor	B-NP	NN	O	12	NMOD	-1
12	progression	progression	I-NP	NN	O	14	NMOD	2	progression
13	and	and	I-NP	CC	O	14	NMOD	-1
14	survival	survival	I-NP	NN	O	10	PMOD	5	survival
15	of	of	B-PP	IN	O	14	NMOD	-1
16	individuals	individual	B-NP	NNS	O	15	PMOD	-1
17	with	with	B-PP	IN	O	16	NMOD	-1
18	gliomas	glioma	B-NP	NNS	O	17	PMOD	-1
19	.	.	O	.	O	8	P	-1

1	The	The	B-NP	DT	O	3	NMOD	-1
2	biological	biological	I-NP	JJ	O	3	NMOD	-1
3	properties	property	I-NP	NNS	O	7	SUB	0
4	of	of	B-PP	IN	O	3	NMOD	-1
5	CCN	CCN	B-NP	NN	B-protein	6	NMOD	-1
6	proteins	protein	I-NP	NNS	I-protein	4	PMOD	-1
7	include	include	B-VP	VBP	O	0	ROOT	-1
8	stimulation	stimulation	B-NP	NN	O	23	NMOD	17	stimulation
9	of	of	B-PP	IN	O	8	NMOD	-1
10	cell	cell	B-NP	NN	O	11	NMOD	-1
11	proliferation	proliferation	I-NP	NN	O	16	NMOD	1	proliferation
12	,	,	O	,	O	16	P	-1
13	migration	migration	B-NP	NN	O	16	NMOD	14	migration
14	,	,	O	,	O	16	P	-1
15	and	and	O	CC	O	16	NMOD	-1
16	adhesion	adhesion	B-NP	NN	O	9	PMOD	15	adhesion
17	,	,	O	,	O	23	P	-1
18	as	as	B-CONJP	RB	O	23	NMOD	-1
19	well	well	I-CONJP	RB	O	18	DEP	-1
20	as	as	I-CONJP	IN	O	18	DEP	-1
21	angiogenesis	angiogenesis	B-NP	NN	O	23	NMOD	3	angiogenesis
22	and	and	I-NP	CC	O	23	NMOD	-1
23	tumorigenesis	tumorigenesis	I-NP	NN	O	7	OBJ	-1
24	.	.	O	.	O	7	P	-1

1	We	We	B-NP	PRP	O	2	SUB	-1
2	quantified	quantify	B-VP	VBD	O	0	ROOT	-1
3	CYR61	CYR61	B-NP	NN	B-protein	12	NMOD	-1
4	,	,	O	,	O	12	P	-1
5	CTGF	CTGF	B-NP	NN	B-protein	12	NMOD	-1
6	,	,	O	,	O	12	P	-1
7	WISP-1	WISP-1	B-NP	NN	B-protein	12	NMOD	-1
8	,	,	O	,	O	12	P	-1
9	and	and	O	CC	O	12	NMOD	-1
10	NOV	NOV	B-NP	NN	B-RNA	11	NMOD	-1
11	mRNA	mRNA	I-NP	NN	I-RNA	12	NMOD	0
12	expression	expression	I-NP	NN	O	13	NMOD	10	expression
13	levels	level	I-NP	NNS	O	2	OBJ	-1
14	in	in	B-PP	IN	O	2	VMOD	-1
15	samples	sample	B-NP	NNS	O	14	PMOD	-1
16	from	from	B-PP	IN	O	15	NMOD	-1
17	sixty-six	sixty-six	B-NP	CD	O	19	NMOD	-1
18	primary	primary	I-NP	JJ	O	19	NMOD	-1
19	gliomas	glioma	I-NP	NNS	O	24	NMOD	-1
20	and	and	O	CC	O	24	NMOD	-1
21	five	five	B-NP	CD	O	24	NMOD	-1
22	normal	normal	I-NP	JJ	O	24	NMOD	-1
23	brain	brain	I-NP	NN	O	24	NMOD	-1
24	samples	sample	I-NP	NNS	O	16	PMOD	-1
25	using	use	B-VP	VBG	O	2	VMOD	-1
26	quantitative	quantitative	B-NP	JJ	O	29	NMOD	-1
27	real-time	real-time	I-NP	JJ	O	29	NMOD	-1
28	PCR	PCR	I-NP	NN	O	29	NMOD	-1
29	assay	assay	I-NP	NN	O	25	OBJ	-1
30	.	.	O	.	O	2	P	-1

1	Statistical	Statistical	B-NP	JJ	O	2	NMOD	-1
2	analysis	analysis	I-NP	NN	O	3	SUB	-1
3	was	be	B-VP	VBD	O	0	ROOT	-1
4	performed	perform	I-VP	VBN	O	3	VC	-1
5	to	to	I-VP	TO	O	6	VMOD	-1
6	explore	explore	I-VP	VB	O	4	VMOD	-1
7	the	the	B-NP	DT	O	8	NMOD	-1
8	links	link	I-NP	NNS	O	6	OBJ	-1
9	between	between	B-PP	IN	O	8	NMOD	-1
10	expression	expression	B-NP	NN	O	19	NMOD	9	expression
11	of	of	B-PP	IN	O	10	NMOD	-1
12	the	the	B-NP	DT	O	14	NMOD	-1
13	CCN	CCN	I-NP	NN	B-DNA	14	NMOD	-1
14	genes	gene	I-NP	NNS	I-DNA	11	PMOD	-1
15	and	and	O	CC	O	19	NMOD	-1
16	clinical	clinical	B-NP	JJ	O	18	AMOD	-1
17	and	and	I-NP	CC	O	18	AMOD	-1
18	pathological	pathological	I-NP	JJ	O	19	NMOD	-1
19	parameters	parameter	I-NP	NNS	O	9	PMOD	-1
20	.	.	O	.	O	3	P	-1

1	Overexpression	Overexpression	B-NP	NN	O	11	SUB	9	Overexpression
2	of	of	B-PP	IN	O	1	NMOD	-1
3	CYR61	CYR61	B-NP	NN	B-protein	10	NMOD	-1
4	,	,	O	,	O	10	P	-1
5	CTGF	CTGF	B-NP	NN	B-protein	10	NMOD	-1
6	,	,	O	,	O	10	P	-1
7	WISP-1	WISP-1	B-NP	NN	B-protein	10	NMOD	-1
8	,	,	O	,	O	10	P	-1
9	and	and	O	CC	O	10	NMOD	-1
10	NOV	NOV	B-NP	NN	B-protein	2	PMOD	-1
11	occurred	occur	B-VP	VBD	O	0	ROOT	-1
12	in	in	B-PP	IN	O	11	VMOD	-1
13	48	48	B-NP	CD	O	14	NMOD	-1
14	%	%	I-NP	NN	O	39	NMOD	-1
15	(	(	O	(	O	19	DEP	-1
16	32	32	B-NP	CD	O	19	DEP	-1
17	of	of	B-PP	IN	O	16	NMOD	-1
18	66	66	B-NP	CD	O	17	PMOD	-1
19	)	)	O	)	O	14	NMOD	-1
20	,	,	O	,	O	39	P	-1
21	58	58	B-NP	CD	O	22	NMOD	-1
22	%	%	I-NP	NN	O	39	NMOD	-1
23	(	(	O	(	O	27	DEP	-1
24	38	38	B-NP	CD	O	27	DEP	-1
25	of	of	B-PP	IN	O	24	NMOD	-1
26	66	66	B-NP	CD	O	25	PMOD	-1
27	)	)	O	)	O	22	NMOD	-1
28	,	,	O	,	O	39	P	-1
29	36	36	B-NP	CD	O	30	NMOD	-1
30	%	%	I-NP	NN	O	39	NMOD	-1
31	(	(	O	(	O	35	DEP	-1
32	24	24	B-NP	CD	O	35	DEP	-1
33	of	of	B-PP	IN	O	32	NMOD	-1
34	66	66	B-NP	CD	O	33	PMOD	-1
35	)	)	O	)	O	30	NMOD	-1
36	,	,	O	,	O	39	P	-1
37	and	and	O	CC	O	39	NMOD	-1
38	15	15	B-NP	CD	O	39	NMOD	-1
39	%	%	I-NP	NN	O	12	PMOD	-1
40	(	(	O	(	O	44	DEP	-1
41	10	10	B-NP	CD	O	42	AMOD	-1
42	of	of	B-PP	IN	O	44	DEP	-1
43	66	66	B-NP	CD	O	42	AMOD	-1
44	)	)	O	)	O	39	NMOD	-1
45	of	of	B-PP	IN	O	39	NMOD	-1
46	primary	primary	B-NP	JJ	O	47	NMOD	-1
47	gliomas	glioma	I-NP	NNS	O	45	PMOD	-1
48	,	,	O	,	O	11	P	-1
49	respectively	respectively	B-ADVP	RB	O	11	VMOD	-1
50	.	.	O	.	O	11	P	-1

1	Interestingly	Interestingly	B-ADVP	RB	O	5	VMOD	-1
2	,	,	O	,	O	5	P	-1
3	significant	significant	B-NP	JJ	O	4	NMOD	-1
4	associations	association	I-NP	NNS	O	5	SUB	-1
5	were	be	B-VP	VBD	O	0	ROOT	-1
6	found	find	I-VP	VBN	O	5	VC	0
7	between	between	B-PP	IN	O	6	VMOD	-1
8	CYR61	CYR61	B-NP	NN	B-protein	9	NMOD	-1
9	expression	expression	I-NP	NN	O	7	PMOD	9	expression
10	versus	versus	B-PP	IN	O	9	NMOD	-1
11	tumor	tumor	B-NP	NN	O	12	NMOD	-1
12	grade	grade	I-NP	NN	O	19	NMOD	-1
13	,	,	O	,	O	19	P	-1
14	pathology	pathology	B-NP	NN	O	19	NMOD	-1
15	,	,	O	,	O	19	P	-1
16	gender	gender	B-NP	NN	O	19	NMOD	-1
17	,	,	O	,	O	19	P	-1
18	and	and	O	CC	O	19	NMOD	-1
19	age	age	B-NP	NN	O	10	PMOD	-1
20	at	at	B-PP	IN	O	19	NMOD	-1
21	diagnosis	diagnosis	B-NP	NN	O	20	PMOD	-1
22	.	.	O	.	O	5	P	-1

1	Also	Also	B-ADVP	RB	O	6	VMOD	-1
2	,	,	O	,	O	6	P	-1
3	a	a	B-NP	DT	O	5	NMOD	-1
4	significant	significant	I-NP	JJ	O	5	NMOD	-1
5	correlation	correlation	I-NP	NN	O	6	SUB	-1
6	existed	exist	B-VP	VBD	O	0	ROOT	-1
7	between	between	B-PP	IN	O	6	VMOD	-1
8	CTGF	CTGF	B-NP	NN	B-RNA	9	NMOD	-1
9	mRNA	mRNA	I-NP	NN	I-RNA	10	NMOD	0
10	levels	level	I-NP	NNS	O	18	NMOD	-1
11	versus	versus	O	CC	O	18	NMOD	-1
12	tumor	tumor	B-NP	NN	O	13	NMOD	-1
13	grade	grade	I-NP	NN	O	18	NMOD	-1
14	,	,	O	,	O	18	P	-1
15	gender	gender	B-NP	NN	O	18	NMOD	-1
16	,	,	O	,	O	18	P	-1
17	and	and	O	CC	O	18	NMOD	-1
18	pathology	pathology	B-NP	NN	O	7	PMOD	-1
19	.	.	O	.	O	6	P	-1

1	In	In	B-PP	IN	O	11	VMOD	-1
2	contrast	contrast	B-NP	NN	O	1	PMOD	-1
3	to	to	B-PP	TO	O	2	NMOD	-1
4	CYR61	CYR61	B-NP	NN	B-protein	6	NMOD	-1
5	and	and	I-NP	CC	O	6	NMOD	-1
6	CTGF	CTGF	I-NP	NN	B-protein	3	PMOD	-1
7	,	,	O	,	O	11	P	-1
8	no	no	B-NP	DT	O	10	NMOD	-1
9	significant	significant	I-NP	JJ	O	10	NMOD	-1
10	association	association	I-NP	NN	O	11	SUB	0
11	was	be	B-VP	VBD	O	0	ROOT	-1
12	found	find	I-VP	VBN	O	11	VC	0
13	between	between	B-PP	IN	O	12	VMOD	-1
14	expression	expression	B-NP	NN	O	13	PMOD	9	expression
15	of	of	B-PP	IN	O	14	NMOD	-1
16	either	either	O	CC	O	19	NMOD	-1
17	WISP-1	WISP-1	B-NP	NN	B-protein	19	NMOD	-1
18	or	or	I-NP	CC	O	19	NMOD	-1
19	NOV	NOV	I-NP	NN	O	15	PMOD	-1
20	versus	versus	B-PP	IN	O	14	NMOD	-1
21	any	any	B-NP	DT	O	20	PMOD	-1
22	of	of	B-PP	IN	O	21	NMOD	-1
23	the	the	B-NP	DT	O	25	NMOD	-1
24	pathological	pathological	I-NP	JJ	O	25	NMOD	-1
25	features	feature	I-NP	NNS	O	22	PMOD	-1
26	.	.	O	.	O	11	P	-1

1	Furthermore	Furthermore	B-ADVP	RB	O	6	VMOD	-1
2	,	,	O	,	O	6	P	-1
3	Cox	Cox	B-NP	NNP	O	5	NMOD	-1
4	regression	regression	I-NP	NN	O	5	NMOD	0
5	analysis	analysis	I-NP	NN	O	6	SUB	-1
6	showed	show	B-VP	VBD	O	0	ROOT	-1
7	that	that	B-SBAR	IN	O	6	VMOD	-1
8	CYR61	CYR61	B-NP	NN	B-protein	11	NMOD	-1
9	and	and	I-NP	CC	O	11	NMOD	-1
10	CTGF	CTGF	I-NP	NN	B-protein	11	NMOD	-1
11	expression	expression	I-NP	NN	O	12	SUB	9	expression
12	had	have	B-VP	VBD	O	7	SBAR	-1
13	a	a	B-NP	DT	O	15	NMOD	-1
14	significant	significant	I-NP	JJ	O	15	NMOD	-1
15	correlation	correlation	I-NP	NN	O	12	OBJ	-1
16	with	with	B-PP	IN	O	15	NMOD	-1
17	patient	patient	B-NP	NN	O	18	NMOD	-1
18	survival	survival	I-NP	NN	O	16	PMOD	5	survival
19	.	.	O	.	O	6	P	-1

1	These	These	B-NP	DT	O	2	NMOD	-1
2	results	result	I-NP	NNS	O	3	SUB	0
3	suggest	suggest	B-VP	VBP	O	30	VMOD	-1
4	that	that	B-SBAR	IN	O	3	VMOD	-1
5	CYR61	CYR61	B-NP	NN	B-protein	7	NMOD	-1
6	and	and	I-NP	CC	O	7	NMOD	-1
7	CTGF	CTGF	I-NP	NN	B-protein	8	SUB	-1
8	may	may	B-VP	MD	O	4	SBAR	-1
9	play	play	I-VP	VB	O	8	VC	0
10	a	a	B-NP	DT	O	11	NMOD	-1
11	role	role	I-NP	NN	O	9	OBJ	0
12	in	in	B-PP	IN	O	9	VMOD	-1
13	the	the	B-NP	DT	O	14	NMOD	-1
14	progression	progression	I-NP	NN	O	12	PMOD	2	progression
15	of	of	B-PP	IN	O	14	NMOD	-1
16	gliomas	glioma	B-NP	NNS	O	15	PMOD	-1
17	;	;	O	:	O	3	P	-1
18	their	their	B-NP	PRP$	O	19	NMOD	-1
19	levels	level	I-NP	NNS	O	22	SUB	-1
20	at	at	B-PP	IN	O	19	NMOD	-1
21	diagnosis	diagnosis	B-NP	NN	O	20	PMOD	-1
22	may	may	B-VP	MD	O	30	VMOD	-1
23	have	have	I-VP	VB	O	22	VC	-1
24	prognostic	prognostic	B-NP	JJ	O	25	NMOD	-1
25	significance	significance	I-NP	NN	O	23	OBJ	-1
26	;	;	O	:	O	30	P	-1
27	and	and	O	CC	O	29	NMOD	-1
28	these	these	B-NP	DT	O	29	NMOD	-1
29	proteins	protein	I-NP	NNS	O	30	SUB	-1
30	might	might	B-VP	MD	O	0	ROOT	-1
31	serve	serve	I-VP	VB	O	30	VC	-1
32	as	as	B-PP	IN	O	31	VMOD	-1
33	valuable	valuable	B-NP	JJ	O	34	NMOD	-1
34	targets	target	I-NP	NNS	O	32	PMOD	0
35	for	for	B-PP	IN	O	34	NMOD	-1
36	therapeutic	therapeutic	B-NP	JJ	O	37	NMOD	-1
37	intervention	intervention	I-NP	NN	O	35	PMOD	-1
